90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignancies.

Paganelli, G

90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignancies. [electronic resource] - Biopolymers 2002 - 393-8 p. digital

Publication Type: Journal Article

0006-3525

10.1002/bip.10349 doi


Humans
Neuroendocrine Tumors--drug therapy
Octreotide--adverse effects
Radiopharmaceuticals--adverse effects
Somatostatin--analogs & derivatives